EXHIBIT 31.1
                                  ------------



                  CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER
                        PURSUANT TO RULE 13a-14(a) OF THE
                   SECURITIES EXCHANGE ACT OF 1934, AS AMENDED
                             AS ADOPTED PURSUANT TO
                  SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002


I, John Y. Yoon, certify that:

1.       I have reviewed this annual report on Form 10-KSB of Paradigm Medical
         Industries, Inc.;

2.       Based on my knowledge, this annual report does not contain any untrue
         statement of a material fact or omit to state a material fact necessary
         to make the statements made, in light of the circumstances under which
         such statements were made, not misleading with respect to the period
         covered by this annual report;


3.       Based on my knowledge, the financial statements, and other financial
         information included in this annual report, fairly present in all
         material respects the financial condition, results of operations and
         cash flows of the registrant as of, and for, the periods presented in
         this annual report;

4.       The registrant's other certifying officers and I are responsible for
         establishing and maintaining disclosure controls and procedures (as
         defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the
         registrant and have:

         (a)  Designed such disclosure controls and procedures, or caused such
              disclosure controls and procedures to be designed under the
              Company's supervision, to ensure that material information
              relating to the registrant, including its consolidated
              subsidiaries, is made known to us by others within those entities,
              particularly during the period in which this annual report is
              being prepared;

         (b)  Evaluated the effectiveness of the registrant's disclosure
              controls and procedures and presented in this annual report the
              Company's conclusions about the effectiveness of the disclosure
              controls and procedures, as of the end of the period covered by
              this annual report based on such evaluation; and

         (c)  Disclosed in this annual report any change in the registrant's
              internal control over financial reporting that occurred during
              registrant's most recent fiscal quarter (the registrant's fourth
              fiscal quarter in the case of an annual report) that has
              materially affected, or is reasonably likely to materially affect,
              registration's internal control over financial reporting; and

5.       The registrant's other certifying officers and I have disclosed, based
         on the Company's most recent evaluation of internal control over
         financial reporting, to the registrant's auditors and the audit
         committee of registrant's board of directors (or persons performing the
         equivalent functions):

         (a)  All significant deficiencies and material weaknesses in the design
              or operation of internal control over financial reporting which
              are reasonably likely to adversely affect the registrant's ability
              to record, process, summarize and report financial information;
              and

         (b)  Any fraud, whether or not material, that involves management or
              other employees who have a significant role in the registrant's
              internal control over financial reporting.


Date: May 12, 2005

                                           /s/ John Y. Yoon
                                           ----------------
                                           John Y. Yoon
                                           President and Chief Executive Officer